Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?

Joseph Zabell; Badrinath Konety

doi:10.21037/tau.2018.08.21

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	S751-S752
Journal	Translational Andrology and Urology
Volume	7
DOIs	https://doi.org/10.21037/tau.2018.08.21
State	Published - Dec 1 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.21037/tau.2018.08.21

Find It

Find It at U of M Libraries

Cite this

@article{0ab749cbc2a64b758e60e50deb014acb,

title = "Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?",

author = "Joseph Zabell and Badrinath Konety",

year = "2018",

month = dec,

day = "1",

doi = "10.21037/tau.2018.08.21",

language = "English (US)",

volume = "7",

pages = "S751--S752",

journal = "Translational Andrology and Urology",